GL1X · GenesisL1 explorer

MolNFT v2 · #156579 · protein

Crystal structure of dimeric RXR-LBD complexed with partial agonist NEt-4IB and TIF2 co-activator

6LB6 · Retinoic acid receptor RXR-alpha: “Crystal structure of dimeric RXR-LBD complexed with partial agonist NEt-4IB and TIF2 co-activator”. X-ray diffraction at 2.4, 1 ligand (E8O), 2 pockets (best druggability 0.84). MolNFT v2 #156579…

PDB
6LB6
Type
protein
Length
221 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.4
Source
Homo sapiens; SYNTHETIC CONSTRUCT
Molecule
Retinoic acid receptor RXR-alpha; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
E8O
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · resolution 2.4 · 2 distinct chains · 70% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor RXR-alphaprotein21170% helix, 3% strandP19793
BNuclear receptor coactivator 2protein1080% helix, 0% strandQ15596

Ligands and binding sites

  • E8O · 6-[ethyl-[4-(2-methylpropoxy)-3-propan-2-yl-phenyl]amino]pyridine-3-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12380.840.9629E8O
21040.360.7421empty

Interfaces

1 interface between chains.

  • A–B · 578 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 6LB6 · Crystal structure of dimeric rxr-lbd complexed with partial agonist net-4IB and TIF2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.